Evidence map›Paper›PMID 21221075›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2011

TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.

Leslie A Bruggeman, Paul E Drawz, Nicole Kahoud, Ke Lin, Laura Barisoni, Peter J Nelson

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  11. Article
  12. Childhood HIV-associated nephropathy: 36 years later.Pediatric nephrology (Berlin, Germany) · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Leslie A BruggemanDepartment of Medicine and Rammelkamp Center for Education and Research, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44109, USA. leslie.bruggeman@case.edu
Paul E Drawz
Nicole Kahoud
Ke Lin
Laura Barisoni
Peter J Nelson
Case Western Reserve University · USNew York University · USUniversity of Washington · US

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2009 to 2023
$20.3M
CWRU NEPHROLOGY TRAINING PROGRAMT32DK007470 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SEDOR, JOHN R. · 1986 to 2019
$2.9M
Immunocytoprotection in collapsing glomerulopathyR01DK083375 · NIDDK · UNIVERSITY OF WASHINGTON · PI NELSON, PETER JACOB · 2009 to 2013
$1.7M
Transcriptional regulation in chronic renal disease pathogenesisR01DK061395 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUGGEMAN, LESLIE A · 2001 to 2008
$1.6M
Epidemiology and pathophysiology of elevated nighttime blood pressure in CKDK23DK087919 · NIDDK · UNIVERSITY OF MINNESOTA · PI DRAWZ, PAUL ENGLUND · 2010 to 2014
$821k
Immune mechanisms in collapsing glomerulopathyK08DK065498 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NELSON, PETER JACOB · 2004 to 2008
$664k
TNF-alpha: an immunologic precipitant of collapsing glomerulopathyR03DK079498 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NELSON, PETER JACOB · 2007 to 2008
$167k
NIAID NIH HHS AI36219NIAID NIH HHS P30 AI036219NIDDK NIH HHS DK007470NIDDK NIH HHS DK061395NIDDK NIH HHS DK065498NIDDK NIH HHS DK079498NIDDK NIH HHS DK083375NIDDK NIH HHS DK083912NIDDK NIH HHS K08 DK065498NIDDK NIH HHS K23 DK087919NIDDK NIH HHS R01 DK061395NIDDK NIH HHS R01 DK083375NIDDK NIH HHS R03 DK079498NIDDK NIH HHS T32 DK007470NIDDK NIH HHS U54 DK083912
6 · The paper itself

Abstract

The development of proliferative podocytopathies has been linked to ligation of tumor necrosis factor receptor 2 (TNFR2) expressed on the renal parenchyma; however, the TNFR2-positive cells within the kidney responsible for podocyte injury are unknown. We detected de novo expression of TNFR2 on podocytes before hyperplastic injury in crescentic glomerulonephritis of mice with nephrotoxic nephritis, and in collapsing glomerulopathy of Tg26(HIV/nl) mice, kd/kd mice, and human beings. We further found that serum levels of soluble TNF-α and TNFR2 correlated significantly with renal injury in Tg26(HIV/nl) mice. Thus, we asked whether ligand binding of TNFR2 on podocytes ex vivo precipitates the characteristic proliferative and pro-inflammatory diseased podocyte phenotypes. Soluble TNF-α activated NF-κB and dose-dependently induced podocyte proliferation, marked by the expression of the podocyte G(1) cyclin and NF-κB target gene, cyclin D1. Microarray gene and chemokine protein expression profiling showed a marked pro-inflammatory NF-κB signature, and activated podocytes secreting CCL2- and CCL5-induced macrophage migration in transwell assays. Neutralization of TNFR2 on podocytes with blocking antibodies abrogated NF-κB activation and the induction of cyclin D1 by TNF-α, and identified TNFR2 as the primary receptor that induced IκBα degradation, the initiating event in NF-κB activation. These results suggest that TNFR2 expressed on podocytes and its canonical NF-κB signaling may directly interpose the compound pathogenic responses by podocytes to TNF-α, in the absence of other TNFR2-positive renal cell types in proliferative podocytopathies.

Indexed as

Cell ProliferationSignal TransductionAnimalsCells, CulturedChemokinesCyclinsGene Expression ProfilingHumansI-kappa B ProteinsKidneyLigandsMiceMice, Inbred C57BLMice, TransgenicNephritisNF-kappa BChemokinesCyclinsI-kappa B ProteinsLigandsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mouseReceptors, Tumor Necrosis Factor, Type IIRNA, MessengerTNFRSF1B protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID21221075
PMCPMC3075956
OpenAlexW2002879179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.